| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8820622 | Revue des Maladies Respiratoires Actualités | 2017 | 10 Pages |
Abstract
To perform a rebiopsy at progression in some subtypes of non-small cell lung cancer is mandatory to improve the management of these patients.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Pulmonary and Respiratory Medicine
Authors
A. Saint-Paul, J. Ballouhey, A. Vergnenègre,